Estimation of Nonalcoholic Fatty Liver Disease in Patients with Normal BMI on Ultrasound by Habiba, Umme et al.
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 




Estimation of Nonalcoholic Fatty Liver Disease in Patients with 
Normal BMI on Ultrasound 
 
Umme Habiba* 
Doctor of Medical Imaging Technology, Department of Allied Health Sciences, Superior College Lahore, 
University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Laraib Afzal 
Doctor of Medical Imaging Technology, Department of Allied Health Sciences, Superior College Lahore, 
University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Waqas Ahmad 
Doctor of Medical Imaging Technology, Department of Allied Health Sciences, Superior College Lahore, 
University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Uttroba Shahid 
Masters in Diagnostics Ultrasound, Lecturer, Department of Allied Health Sciences, Superior College Lahore, 
University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Mansoor Bkhtiary 
MBBS, MCPS, DMRD 
Radiologists in DHA Medical Centre, Lahore. 
 
Rana Muhammad Athar Azeem Shams 
Masters in Medical Imaging Technology, Lecturer, Department of Allied Health Sciences, Superior College 
Lahore, University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Rana Muhammad Bakhtawar Khan Sajawal 
Masters in Mathematics, Lecturer, Department of Allied Health Sciences, Superior College Lahore, University 
Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
Amna Babar 
Masters in Diagnostic Ultrasound, Lecturer, Department of Allied Health Sciences, Superior College Lahore, 
University Campus, 17-KM Raiwaind Road, Kot Arain, Lahore, Pakistan 
 
The research is financed by Asian Development Bank. No. 2006-A171(Sponsoring information) 
Abstract 
Background: Non-Alcoholic fatty liver disease is common in adults and it is increasing in patients with normal 
BMI in Asian countries. Non-alcoholic fatty liver disease (NAFLD) occurs not only in obese individuals but also 
in non-obese ones. The association between NAFLD and metabolic events in a non-obese population is also 
evident.. 
Objective: To estimate nonalcoholic fatty liver disease in patients with normal BMI on ultrasound.  
Methodology: Analytical Cross-sectional prospective study in which 59 patients were enrolled in the research. 
All the patient’s data had been composed from indoor of hospital, outdoor of hospital, DHA Medical Center, 
Lahore. After well-versed consent, data was composed through ultrasound machine. The data, such as patient 
characteristics, hypertension, impaired fasting glucose, were extracted from medical records, and statistical 
analysis was performed. 
Results: The present study is retrospective cross sectional observational study.60 patients (29males 49.2% 31 
female 50.8%) were enrolled in this study. According to abdominal ultrasonography, 72.9% of patients with 
normal BMI were diagnosed to have Non-alcoholic fatty liver disease and identified to have fatty changes in the 
liver. 
Conclusion: In our study we estimated that nonalcoholic fatty liver disease was present in patients with normal 
body mass index by imaging the echotexture of liver on ultrasound. Having increased echogenicity, due to poor 
diet and other associated diseases such as high blood pressure, impaired fasting glucose and low HDL 
cholesterol patients were getting NAFLD. 
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A chronic liver disease that has showed progress in cirrhosis and hepatocellular cancer is nonalcoholic fatty liver 
disorder (NAFLD). NAFLD seems closely associated with obesity and insulin resistance, including diabetes, and 
other metabolic syndrome characteristics, such as high triglycerides and low HDL. 
The estimated prevalence in the general population ranges from 3% to 24%, with the most estimates 
ranging from 6% to 14%. Some data imply that Mexican Americans are more likely than non-Hispanic whites to 
have NAFLD while blacks are less prevalent. The advanced phases of NAFLD include old age, greater levels of 
body mass, diabetes, high blood pressure, high triglycerides and/or resistance to insulin. More severe illness can 
also be shown by an AST/ALT ratio of more>1.[1] In the past decade, the antagonism to insulin has been viewed 
as the main hidden weapon of pathophysiology despite its absence in fully influencing people. A significant 
pathophysiological component is NAFLD which is particularly weight-driven insulin opposition. Fiery angles 
are also of pivitol importance especially in fibrosis associated with NASH and NASH, usually resulting in an 
overpowering fire in the liver.[2] Heaviness, type 2 diabetes, metabolism, including dyslipidemias and 
hypertension is the most important risk component of NAFLD. Hepatic fat can be associated with infections 
other than the metabolic conditions, which could lead to the differential conclusion of a common fatty liver 
disease. Because of the evident amount of fatty tissue in lean patients, i.e. BMI da 25.0 kg/m2, there may be 
contrasts among sleek and contrasting NAFLD disease components with heavy patients.[3] Liver is a sequestered, 
reddish earthy structure with two flaps of varying form and size. Human liver generally takes approximately 1,5 
kilograms (3.3 lb) and is approximately 15 cm wide (6 in). Specific reference limit is 971–1,861 g (2,13–4,11 
pound) for males and 600–1,771 g for ladies (1,31–3.90 pound) of men. The size varies substantially across men. 
Either the heaviest structure within human humans and the largest organ. It lies underneath the stomach on one 
side of the stomach and surmounts the gallic bladder in the right upper region of the stomach depression.[4] When 
viewed from a higher place – a pre-requisite and a left flap – the liver is brutally divided into two halves and the 
quadrilateral parts are observed underneath all liver lobes. In the middle area of the hepatic hilum, the opening 
known as the porta hepatis is integrated, which provides the standard bile channel and the base liver duct. On 
condition that these parts are useful, the ductal, vein and course division into left and right branches and the 
regions of the hepatic make protrusions of the left and right side.[5] It takes a role in the production, 
multiplication and development of chemical digestion and process transporting proteins. Finally, cups and 
primary cells play an important role in the resistive structure of the body. Bile is a major liquid since it releases a 
product not released by excretory systems and helps with phospholipid intake and treatment by emitting salts and 
acids from digestive juices. The bile comes from keratinocytes and, although the various chemicals are not 
present, mainly consisting of water, electrodialyzes, steroids, bile acids, cholesterol, bile pigment, bilirubin and 
phospholipids.[6] The liver is considered to be normal in ultrasound if the echotexture is uniform with no acoustic 
restriction; the portable veins are Obvious, stomach is extremely visual and the echogenicity of the renal 
parenchyma can be compared to or marginally higher. The liver is described as fatty liver if the liver has zones 
of echogenicity that are substantially increased, comparative to renal parenchyma, the stomach ultrasonography 
bar is constrained or the portal vein echo-dividers are less visible.[7] As a metric to quantify obesity the body 
mass index BMI is >30kg/ms2. Many patients without obesity (up to 25%) suffer from NASFLD, leading to 
cardiovascular disease and diabetes in Asians among patients with normal BMI. It is vital for patients with 
NAFLD to be investigated for metabolic syndrome and to have detrimental outcomes with respect to the normal 
BMI.[8] 
 
1.1 Material and Methods 
This is an analytical cross-sectional study. The data was collected from DHA Medical Centre, Lahore. the 
duration of data study was from January to May 2021. Total 59 subjects were enrolled is this which completed 
the inclusion criteria of this study.  Patients having normal BMI 18-25kg/ms2 and above 18 years were included. 
Patients having Hepatitis B and C, iron deficiency and who consumed alcohol are excluded. Ultrasound machine, 
Apollo, was used with convex probe of 3-5 MHz Body mass index was calculated by patient’s height and weight. 
After calculation transabdominal scan was performed. Liver parenchyma, echogenicity and fatty appearance was 
observed. Afterwards, patients’ blood pressure was measured by using sphygmomanometer. 120/80 is normal 
parameter above this level it is declared as high BP. Blood glucose was measured when patient was in fasting 
state. 110 is normal measurement above and below this level was labelled as impaired fasting glucose. Other 
variables like regular exercise, low HDL cholesterol and smoking was taken from patient history and from 
medical records. Body fat percentage was calculated from BMI and Age of the patients. SPSS Computer 
software, version 25 was used to analysis the data. The rules and regulations set by the ethical committee of The 
Superior College were followed while conducting the research and the rights of the research participants were 
respected. Written informed consent form attached was taken from all the participants. 
1.1.1 Results: 
A total of 59 patients in which 29 were males and 30 were females with Nonalcoholic fatty liver disease having 
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normal BMI. The mean patients were 39.17 and 12.34 years old on average. 72.9% of patients having increased 
echogenicity was labeled as nonalcoholic fatty liver disease. Below are graphs of the average of the echotexture, 
impaired fasting glucose, low HDL cholesterol, regular exercise, smoking and body fat percentage. 
1.1.2 Discussion: 
A research conducted in Bangladesh in 2020 by M Masudur Rahman, et al aims to determine the generality of 
non-hefty corpulent NAFLD, consider the clinical and metabolic sociodemographic attributes between non-
stopping and fat NAFLD subjects and determine the hazardous components of the NAFLD. It had 18.5% of its 
members, one quarter of them were bodyless. The metabolic profile of the sizeful and unheavy NAFLD was 
equivalent in addition to the weight list. The nonalcoholic fatty liver disease and its deleterious effects should be 
evaluated and monitored by general welfare measures. In 57/804 (7.1%) of the non-hefty and 185/501(36.93%) 
of the overweight members, NAFLD was recognised. Of the magic topics, NAFLD had 24/592 (4.1%). Fifty-
seven (23.55%) of NAFLDs had non-stop, with alanine amino-transferase elevated by five (22%) individuals. 
The risk variables for NAFLD have been established during multivariate analysis, age>40 years, male sex, 
metabolism (MS), diabetes mellitus (DM), stomach corpulence, high blood pressure, dyslipidemia and heftiness. 
Ren-Nan Feng et al. (2014) In China, analyse NAFLD's high. NAFLD patients were more seasoned, more BMI-
contaminated, with abdominal periphery, pulse, fasting blood glucose and insulin. Although lean-NAFLD 
patients had a reduced BMI and intersectional situation, the instinctive adiposity record was substantially greater 
than that of overweight body checks. Patients with Lean-NAFLD had overweight fatty oil, cholesterol for 
NAFLD patients with a low thickness of lipoprotein. 
Hyperlipidemia, hypertension, diabetes and metabolic disease were endangered by all NAFLD patients 
(MetS). The overweight NAFLD (only OOR for MetS was significant: OR=1.89; 95% CI:1.29–2.77) was more 
clearly associated to diabetes (OR=2.47; 95% CI: 1.14–5.35), hypertension (or = 1.72; 95% CI: 1.00-2.96) and 
MetS (OR+=3.19; and 95% CI: 1.17–4.05). NFLD patients were linked to focal stoutness, notably in lean 
assemblages (OR = 1.97, 95 percent CI: 1.38-2.80), or OR = 2.17, 95 percent C I: 1.17-4.05). 
Our study was very much similar with their study, in our study we have discussed mainly   the clinical 
representation of NAFLD in patients with normal BMI on ultrasound. We estimated that patients with normal 
BMI were likely to suffer from NAFLD due to their lack of regular exercise and poor diet routine which led 
them to other diseases like high blood pressure, diabetes mellitus etc. In our study aggregate of 59 patients 
(29male -49.2% and 30 female-50.8%). were designated. 43 patients with normal BMI 18-25kgms2 from total 
population have increased liver echogenicity seen on ultrasound. And these patients were also associated with 
impaired fasting glucose and high blood pressure. It is concluded from the study that 62.7% of people have low 
HDL cholesterol less than 40 and body fat percentage were calculated according to age and BMI of patient. Data 
were selected from individuals who were sent for abdominal USG. Ultrasonographic investigation was done on 
patients with normal BMI and then other factors like impaired fasting glucose, low HDL cholesterol, high blood 
pressure, regular exercise and body fat percentage were also investigated. 
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N Valid 59 59 59 59 59 59 59 59 59 59
Missing 0 0 0 0 0 0 0 0 0 0
Mean 39.17 .49 1.73 1.47 .69 1.36 1.54 .51 1.37 1.73
Mode 45 0 2 1 1 1 1 1 1 2
Minimum 21 0 1 1 0 1 1 0 1 1
Maximum 72 1 3 2 1 2 3 1 2 2
 
Regular Exercise 
 Frequency Percent Valid Percent Cumulative Percent 
Valid YES 31 52.5 52.5 52.5 
NO 28 47.5 47.5 100.0 
Total 59 100.0 100.0  
 
High Blood Pressure 
 Frequency Percent Valid Percent Cumulative Percent 
Valid NO 18 30.5 30.5 30.5 
YES 41 69.5 69.5 100.0 
Total 59 100.0 100.0  
 
Impaired fasting glucose 
 Frequency Percent Valid Percent Cumulative Percent 
Valid YES 38 64.4 64.4 64.4 
NO 21 35.6 35.6 100.0 
Total 59 100.0 100.0  
 
Body Fat Percentage 
 Frequency Percent Valid Percent Cumulative Percent 
Valid 20-39(8-19%) 30 50.8 50.8 50.8 
40-59(11-21%) 26 44.1 44.1 94.9 
60-79(13-24%) 3 5.1 5.1 100.0 
Total 59 100.0 100.0  
 
Smoking 
 Frequency Percent Valid Percent Cumulative Percent 
Valid NO 29 49.2 49.2 49.2 
YES 30 50.8 50.8 100.0 
Total 59 100.0 100.0  
 
Low HDL Cholesterol 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Less than 40 37 62.7 62.7 62.7 
Less than 60 22 37.3 37.3 100.0 
Total 59 100.0 100.0  
 
Echotexture 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Normal 16 27.1 27.1 27.1 
Increased Echogenicity 43 72.9 72.9 100.0 
Total 59 100.0 100.0  
Table no 1: frequency tables for age, gender BMI, regular exercise, low HDL cholesterol, impaired fasting 
glucose, smoking and high blood pressure. 
 
